104 related articles for article (PubMed ID: 1711749)
1. [Significant effects on alpha-fetoprotein (AFP) concentration in maternal serum in pregnancy].
Greiff R; Schlosser H; Amse T
Zentralbl Gynakol; 1991; 113(5):253-7. PubMed ID: 1711749
[TBL] [Abstract][Full Text] [Related]
2. Reproductive factors and extreme levels of maternal serum alpha-fetoprotein: a population-based study.
Lei U; Wohlfahrt J; Christens P; Westergaard T; Lambe M; Nørgaard-Pedersen B; Melbye M
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1147-51. PubMed ID: 15548147
[TBL] [Abstract][Full Text] [Related]
3. Co-variables in first trimester maternal serum screening.
de Graaf IM; Cuckle HS; Pajkrt E; Leschot NJ; Bleker OP; van Lith JM
Prenat Diagn; 2000 Mar; 20(3):186-9. PubMed ID: 10719318
[TBL] [Abstract][Full Text] [Related]
4. [Determination of maternal serum alpha fetoprotein with a Polish AFP radioimmunoassay--a suitable screening method for neural tube defects?].
Schlosser H; Greiff R
Zentralbl Gynakol; 1986; 108(15):914-8. PubMed ID: 2429479
[TBL] [Abstract][Full Text] [Related]
5. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
[TBL] [Abstract][Full Text] [Related]
6. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
Milunsky A; Alpert E; Neff RK; Frigoletto FD
Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
[TBL] [Abstract][Full Text] [Related]
7. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum alpha-fetoprotein in normal pregnancy at 11-13 weeks' gestation.
Bredaki FE; Wright D; Akolekar R; Cruz G; Nicolaides KH
Fetal Diagn Ther; 2011; 30(4):274-9. PubMed ID: 22156386
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
[TBL] [Abstract][Full Text] [Related]
10. Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy.
González-Bugatto F; Foncubierta E; Bailén Mde L; Illanes S; Hervías-Vivancos B; Bartha JL
J Obstet Gynaecol Res; 2009 Apr; 35(2):271-6. PubMed ID: 19453690
[TBL] [Abstract][Full Text] [Related]
11. [Relation between the body weight of the pregnant patient and her serum alpha fetoprotein levels].
Gardó S; Wessely J
Zentralbl Gynakol; 1985; 107(1):31-4. PubMed ID: 2580404
[TBL] [Abstract][Full Text] [Related]
12. Very low alpha-fetoprotein in Down syndrome maternal serum screening.
Muller F; Dreux S; Sault C; Galland A; Puissant H; Couplet G; Lemay C; Larcher ME; Renom G;
Prenat Diagn; 2003 Jul; 23(7):584-7. PubMed ID: 12868089
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum transformed alpha-fetoprotein levels in women with intrauterine growth retardation.
Bartha JL; Illanes S; González-Bugatto F; Abdel-Fattah SA; Mizejewski GJ; Soothill PW
Fetal Diagn Ther; 2007; 22(4):294-8. PubMed ID: 17361083
[TBL] [Abstract][Full Text] [Related]
14. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
[TBL] [Abstract][Full Text] [Related]
15. Alpha fetoprotein levels in newborn infants with reference to sex, gestational age and birth weight.
Bansal V; Kumari K; Dixit A; Sahib MK
Indian J Exp Biol; 1989 Jul; 27(7):666-7. PubMed ID: 2483717
[TBL] [Abstract][Full Text] [Related]
16. [Increased AFP in maternal serum as an indication for invasive diagnosis].
Gremm B; Sohn C; Beldermann F; Bastert G
Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
Ashwood ER; Cheng E; Luthy DA
Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
[TBL] [Abstract][Full Text] [Related]
18. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
[TBL] [Abstract][Full Text] [Related]
19. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
Sancken U; Bartels I
Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
[TBL] [Abstract][Full Text] [Related]
20. AFP and age screening for Down syndrome.
Wald N; Cuckle H
Am J Med Genet; 1988 Sep; 31(1):197-209. PubMed ID: 2464930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
